- Brand name: Sandoglobulin®
- Generic name: Intravenous Immunoglobulin (IVIG)
- Indication:
-Congenital agammaglobulinaemia and hypogammaglobulinaemia
-Common variable immunodeficiency
-Severe combined immunodeficiency
-IgG subclass deficiencies
-Wiskott-Aldrich syndrome
- Secondary immunodeficiency syndromes associated with:
- Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections
- Children with congenital AIDS and recurrent infections
- Allogenic bone marrow transplantation
- Primary immune thrombocytopenia (ITP) in children or adults at high risk of
bleeding or prior to surgery to correct the platelet count
- Kawasaki disease
- Guillain-Barré syndrome
- Additional indications approved by individual countries are:
- Treatment of severe bacterial infections including sepsis, or viral infections, in combination with antibacterial or antiviral agents
- Prevention of infection in premature, low birth weight infants (< 1500g)
- Treatment of chronic inflammatory demyelinating polyneuropathy
- Treatment of severe multifocal motor neuropathy with conduction block
- Treatment of autoimmune neutropenia and autoimmune haemolytic anaemia
- Treatment of autoantibody-mediated pure red-cell aplasia
- Treatment of thrombocytopenia of immunological origin, such as posttransfusion purpura or isoimmune thrombocytopenia of the neonate
- Treatment of haemophilia caused by the formation of autoantibodies to factor VIII
- Treatment of myasthenia gravis
- Prevention and treatment of infection occurring with cytostatic and immunosuppressive medication
- Prevention of recurrent spontaneous abortion
- Treatment of severe steroid-dependent childhood asthma
- Dosage form: Lyophilisate for solution for intravenous administration, Vial, 6g
- Manufacturer: CSL Behring AG
- Country of origin: Switzerland